Treatment of irritable bowel syndrome

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 3, 2011, Pages 275-282

  Trinkley, K E ^a   Nahata, M C ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

efficacy; irritable bowel syndrome; medications; symptoms; therapy

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLONIDINE; DESIPRAMINE; DICYCLOVERINE; DOXEPIN; FLUOXETINE; GABAPENTIN; HYOSCYAMINE; IMIPRAMINE; ISPAGULA; LOPERAMIDE; LUBIPROSTONE; OCTREOTIDE; PAROXETINE; PEPPERMINT OIL; PLACEBO; PREGABALIN; PROBIOTIC AGENT; RIFAXIMIN; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ABDOMINAL PAIN; BLOATING; BRAN; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FLATULENCE; FOLLOW UP; HEALTH CARE COST; HUMAN; IRRITABLE COLON; MYALGIA; QUALITY OF LIFE; REVIEW; SYMPTOM; TREATMENT OUTCOME;

ABDOMINAL PAIN; ANTIDEPRESSIVE AGENTS; ANTIDIARRHEALS; CONSTIPATION; CONTROLLED CLINICAL TRIALS AS TOPIC; DEPRESSION; DIARRHEA; DIETARY FIBER; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; IRRITABLE BOWEL SYNDROME; PARASYMPATHOLYTICS; QUALITY OF LIFE;

EID: 79955765561     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01177.x     Document Type: Review

References (51)

1. Brandt LJ, Bjorkman D, Fennerty B, et al. (2002) Systematic review on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97, s7-s26.
2. Drossman DA, Camilleri M, Mayer EA, Whitehead WE, (2002) AGA technical review on irritable bowel syndrome. Gastroenterology, 123, 2108-2131. (Pubitemid 35408332)
3. Bassett JT, Cash BD, (2008) A review of irritable bowel syndrome and an update on therapeutic approaches. Expert Opinion on Pharmacotherapy, 9, 1129-1143. (Pubitemid 351721751)
4. Spiegel B, Strickland A, Naliboff BD, Mayer EA, Chang L, (2008) Predictors of patient-assessed illness severity in irritable bowel syndrome. American Journal of Gastroenterology, 103, 2536-2543.
5. American Gastroenterology Association (2002) American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterolology, 123, 2105-2107.
6. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. (2009) An evidence-based position statement on the management of irritable bowel syndrome. American Journal of Gastroenterology, 104, s1-s35.
7. Hovdenak N, (1987) Loperamide treatment of the irritable bowel syndrome. Scandinavian Journal of Gastroenterology Supplement, 130, 81-84. (Pubitemid 17112890)
8. Cann PA, Read NW, Holdsworth CD, Barends D, (1984) Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Digestive Diseases and Science, 29, 239-247. (Pubitemid 14158881)
9. Efskind PS, Bernklev T, Vatn MH, (1996) A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. Scandinavian Journal of Gastroenterology, 31, 463-468. (Pubitemid 26153637)
10. Prior A, Whorwell PJ, (1987) Double blind study of ispaghula in irritable bowel syndrome. Gut, 28, 1510-1513. (Pubitemid 17164088)
11. Jalihal A, Kurian G, (1990) Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction. Journal of Gastroenterolology and Hepatology, 5, 507-513. (Pubitemid 20302088)
12. Arthurs Y, Fielding JF, (1983) Double blind trial of ispaghula/poloxamer in the irritable bowel syndrome. Irish Medical Journal, 76, 253. (Pubitemid 13044453)
13. Ritchie JA, Truelove SC, (1979) Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. British Medical Journal, 1, 376-378. (Pubitemid 9095236)
14. Longstreth GF, Fox DD, Youkeles L, Forsythe AB, Wolochow DA, (1981) Psyllium therapy in the irritable bowel syndrome. A double-blind trial. Annals of Internal Medicine, 95, 53-56. (Pubitemid 11079020)
15. Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW, (2009) Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ, 339, b3154.
16. Rajagopalan M, Kurian G, John J, (1998) Symptom relief with amitriptyline in the irritable bowel syndrome. Journal of Gastroenterolology and Hepatology, 13, 738-741. (Pubitemid 28407348)
17. Bahar RJ, Collins BS, Steinmetz B, Ament ME, (2008) Double-blind, placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. Journal of Pediatrics, 152, 685-689.
18. Myren J, Groth H, Larssen SE, Larsen S, (1982) The effect of trimipramine in patients with the irritable bowel syndrome. Scandinavian Journal of Gastroenterology, 17, 871-875. (Pubitemid 12032572)
19. Myren J, Lovland B, Larssen SE, Larsen S, (1984) A double-blind study of the effect of trimipramine in patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology, 19, 835-843. (Pubitemid 14027537)
20. Vij JG, Jiloha RG, Kumar N, et al. (1991) Effect of antidepressant drug (doxepin) on irritable bowel syndrome patients. Indian Journal of Psychiatry, 33, 243-246.
21. Greenbaum DS, Mayle JE, Vanegeren LE, et al. (1987) Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Digestive Disease and Sciences, 32, 257-266. (Pubitemid 17054266)
22. Heefner JD, Wilder RM, Wilson ID, (1978) Irritable colon and depression. Psychosomatics, 19, 540-547. (Pubitemid 9068233)
23. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M, (2008) Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Digestive Disease and Sciences, 53, 108-115. (Pubitemid 350265657)
24. Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J, (2006) A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut, 55, 1095-1103. (Pubitemid 44085674)
25. Kuiken SD, Tytgat GNJ, Boeckxstaens GEE, (2003) The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clinical Gastroenterology and Hepatology, 1, 219-228. (Pubitemid 37248073)
26. Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R, (2005) The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Alimentary Pharmacology and Therapeutics, 22, 381-385. (Pubitemid 41248104)
27. Masand PS, Pae CU, Krulewicz S, Peindl K, Mannelli P, Varia IM, Patkar AA, (2009) A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics, 50, 78-86.
28. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L, (2007) Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double-blind placebo controlled randomized trial. Digestive and Liver Disease, 39, 530-536. (Pubitemid 46746646)
29. Liu JH, Chen GH, Yen HZ, Huang CK, Poons K, (1997) Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. Journal of Gastroenterology, 32, 765-768.
30. Lee KJ, Kim JH, Cho SW, (2005) Gabapentin reduces rectal mechanosensitivy and increases compliance in patients with diarrhea-predominant irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 22, 981-988. (Pubitemid 41634880)
31. Pimentel M, Sandy P, Mirocha J, Kane SV, Kong Y, (2006) The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome. Annals of Internal Medicine, 145, 557-563. (Pubitemid 46780934)
32. 2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut, 56, 1218-1225. (Pubitemid 47300421)
33. Whorwell PJ, Altringer L, Morel J, et al. (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology, 101, 1581-1590. (Pubitemid 43980633)
34. Enck P, Zimmerman K, Menke G, Klosterhalfen S, (2009) Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Zeitschrift für Gastroenterologie, 47, 209-214.
35. Enck P, Zimmermann K, Menke G, Muller-Lissner S, Martens U, Klosterhalfen S, (2008) A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome-a randomized controlled trial with primary care physicians. Neurogastroenterology and Motility, 20, 1103-1109.
36. Niedzierlin K, Kordecki H, Birkenfeld B, (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European Journal of Gastroenterology and Hepatology, 13, 1143-1147. (Pubitemid 33015878)
37. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P, (2008) A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroentérologie Clinique et Biologique, 32, 147-152. (Pubitemid 351637577)
38. Hun L, (2009) Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgraduate Medicine, 121, 119-124.
39. Kajander K, Myllyluoma E, Rajilic-Stojanovic M, (2008) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology and Therapeutics, 27, 48-57. (Pubitemid 350212625)
40. O'Mahony L, McCarthy J, Kelly P, et al. (2005) Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology, 128, 541-551. (Pubitemid 40585355)
41. Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R, (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Alimentary Pharmacology and Therapeutics, 22, 387-394. (Pubitemid 41248105)
42. Kim HJ, Vazquez Roque MI, Camilleri M, et al. (2005) A randomized controlled trial of a probiotic combination VSL #3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterology and Motility, 17, 687-696. (Pubitemid 41400717)
43. Niv E, Naftali T, Hallak R, Vaisman N, (2005) The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome-a double blind, placebo-controlled, randomized study. Clinical Nutrition, 24, 925-931. (Pubitemid 41782449)
44. Bausserman M, Michail S, (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. Journal of Pediatrics, 147, 197-201. (Pubitemid 41207833)
45. Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R, (2008) Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 27, 685-696. (Pubitemid 351406304)
46. Lembo A, Zakko SF, Ferreira NL, et al. (2008) T1390 Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: short term treatment leading to long term sustained response. Gastroenterology, 134 AGA Abstracts A-545.
47. Page JG, Dirnberger GM, (1981) Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). Journal of Clinical Gastroenterology, 3, 153-156. (Pubitemid 11113503)
48. Lavo B, Stenstam M, Nielsen AL, (1987) Loperamide in treatment of irritable bowel syndrome-a double blind placebo controlled study. Scandinavian Journal of Gastroenterology, 130, S77-S80.
49. Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R, (2008) Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 27, 678-684. (Pubitemid 351406307)
50. Camilleri M, Kim DY, Mckinzie S, et al. (2003) A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 1, 111-121. (Pubitemid 37248082)
51. Klooker TK, Kuiken SD, Lei A, Boeckxstaens GE, (2007) Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 26, 605-615. (Pubitemid 47174283)